[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Oh Hyung-gil] The daily number of COVID-19 vaccine recipients for the first and second doses combined increased by more than 150,000. Nearly 3.76 million people, accounting for 7.3% of the entire population, have completed their first dose, and over 1.18 million have completed their second dose.


According to the COVID-19 Vaccination Response Promotion Team (Promotion Team) on the 19th, on the 18th alone, 11,822 people received their first dose, and 139,678 completed their second dose, totaling 151,500 vaccinations.


Among the new first-dose recipients, 2,876 received the AstraZeneca-Oxford vaccine, and 8,946 received the Pfizer-BioNTech vaccine.


Including 2,263 people registered after the vaccination date, a cumulative total of 3,759,058 people have received their first dose since February 26. This accounts for approximately 7.3% of the total population (51,349,116 people, based on the resident registration population as of December 2020).


The number of people who have completed their second dose increased by 38,106 for AstraZeneca and 101,572 for Pfizer, reaching 1,180,281, which is 2.3% of the total population. By vaccine type, 61,152 people received the AstraZeneca vaccine, and 1,121,290 received the Pfizer vaccine.


There were 925 new reports of suspected adverse reactions following COVID-19 vaccination over the two days from the 17th to the 18th, bringing the total to 23,124 cases. Among these, 386 were AstraZeneca recipients, and 539 were Pfizer recipients.



There were 17 additional reports of suspected deaths, including 1 AstraZeneca recipient and 16 Pfizer recipients, bringing the cumulative total to 140.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing